Browsing by Author Lu, S.

Showing results 1 to 2 of 2
Issue DateTitleAuthor(s)
2024Amivantamab Plus Lazertinib Vs Osimertinib in First Line, Egfr-Mutant Advanced Nsclc: Patientrelevant Outcomes From MariposaNguyen, D.; Besse, B.; Cho, B. C.; Lee, S. -H.; Lee, K. H.; Lu, S.; Garcia Campelo, M. R.
2024Pod1um-304: Phase Iii Study of Retifanlimab Plus Platinum-Based Chemotherapy (Chemo) as First-Line (1l) Therapy for Nonsquamous or Squamous Metastatic Nonesmall Cell Lung Cancer (Mnsclc)Lu, S.; Vynnychenko, O.; Kulyaba, Y.; Kuchava, V.; Ibrahim, A.; Moiseenko, F. V.; Bondarenko, I.